MYB is essential for mammary tumorigenesis

Cancer Research

Volumn 71, Issue 22, 2011, Pages 7029-7037

  Miao, Rebecca Yu ^a,c   Drabsch, Yvette ^b,d   Cross, Ryan Stanley ^a   Cheasley, Dane ^a   Carpinteri, Sandra ^a   Pereira, Lloyd ^a   Malaterre, Jordane ^a   Gonda, Thomas J ^b   Anderson, Robin L ^a   Ramsay, Robert G ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c STANFORD UNIVERSITY   (United States)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR ALPHA; MESSENGER RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER CELL; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE LOSS; GENE TARGETING; GENOTYPE; MOUSE; MYB GENE; NONHUMAN; ONCOGENE; PRIORITY JOURNAL; TUMOR CELL; TUMOR GROWTH;

ANIMALS; ANTIGENS, VIRAL, TUMOR; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; ETHYLNITROSOUREA; FEMALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; ONCOGENE PROTEINS V-MYB; RECEPTOR, ERBB-2;

EID: 81155126048     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-1015     Document Type: Article

References (49)

1. Vargo-Gogola T, Rosen JM. Modelling breast cancer: one size does not fit all. Nat Rev Cancer 2007;7:659-72. (Pubitemid 47327411)
2. Blackshear PE. Genetically engineered rodent models of mammary gland carcinogenesis: an overview. Toxicol Pathol 2001;29:105-16. (Pubitemid 32127329)
3. Lund MJ, Trivers KF, Porter PL, Coates RJ, Leyland-Jones B, Brawley OW, et al. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA. Breast Cancer Res Treat 2009;113:357-70.
4. Schneider BP, Winer EP, Foulkes WD, Garber J, Perou CM, Richardson A, et al. Triple-negative breast cancer: risk factors to potential targets. Clin Cancer Res 2008;14:8010-8.
5. Campeau PM, FoulkesWD, Tischkowitz MD. Hereditary breast cancer: new genetic developments, new therapeutic avenues. Hum Genet 2008;124:31-42.
6. Drabsch Y, Hugo H, Zhang R, Dowhan DH, Miao YR, Gewirtz AM, et al. Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells. Proc Natl Acad Sci U S A 2007;104:13762-7. (Pubitemid 350003394)
7. Zhao L, Glazov EA, Pattabiraman DR, Al-Owaidi F, Zhang P, Brown MA, et al. Integrated genome-wide chromatin occupancy and expression analyses identify key myeloid pro-differentiation transcription factors repressed by Myb. Nucleic Acids Res 2011;39:4664-79.
8. Quintana AM, Liu F, O'Rourke JP, Ness SA. Identification and regulation of c-Myb target genes in MCF-7 cells. BMC Cancer 2011;11:30.
9. Ramsay RG, Gonda TJ. MYB function in normal and cancer cells. Nat Rev Cancer 2008;8:523-34. (Pubitemid 351881853)
10. Drabsch Y, Ramsay RG, Gonda TJ. MYB suppresses differentiation and apoptosis of human breast cancer cells. Breast Cancer Res 2010;12:R55.
11. Foulkes WD, Stefansson IM, Chappuis PO, Begin LR, Goffin JR, Wong N, et al. Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 2003;95:1482-5. (Pubitemid 37279334)
12. Kauraniemi P, Hedenfalk I, Persson K, Duggan DJ, Tanner M, Johannsson O, et al. MYB oncogene amplification in hereditary BRCA1 breast cancer. Cancer Res 2000;60:5323-8.
13. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci U S A 1992;89:10578-82.
14. Guy CT, Cardiff RD, Muller WJ. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol 1992;12:954-61.
15. Emambokus N, Vegiopoulos A, Harman B, Jenkinson E, Anderson G, Frampton J. Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb. Embo J 2003;22:4478-88. (Pubitemid 37087201)
16. Wagner KU, Wall RJ, St-Onge L, Gruss P, Wynshaw-Boris A, Garrett L, et al. Cre-mediated gene deletion in themammary gland. Nucleic Acids Res 1997;25:4323-30. (Pubitemid 27485212)
17. Zorbas M, Sicurella C, Bertoncello I, Venter D, Ellis S, Mucenski ML, et al. c-Myb is critical for murine colon development. Oncogene 1999;18:5821-30. (Pubitemid 29507436)
18. Aslakson CJ, Miller FR. Selective events in the metastatic process defined by analysis of the sequential dissemination of subpopulations of a mouse mammary tumor. Cancer Res 1992;52:1399-405.
19. Masibay A, Mozer TJ, Sprecher C. Promega Corporation reveals primer sequences in its testing kits. J Forensic Sci 2000;45:1360-2.
20. Rayner JR, Gonda TJ. A simple and efficient procedure for generating stable expression libraries by cDNA cloning in a retroviral vector. Mol Cell Biol 1994;14:880-7. (Pubitemid 24036537)
21. Ramsay RG, Ciznadija D, Mantamadiotis T, Anderson R, Pearson R. Expression of stress response protein glucose regulated protein-78 mediated by c-Myb. Int J Biochem Cell Biol 2005;37:1254-68. (Pubitemid 40381201)
22. Ramsay RG, Ishii S, Nishina Y, Soe G, Gonda TJ. Characterization of alternate and truncated forms of murine c-myb proteins. Oncogene Res 1989;4:259-69. (Pubitemid 19200682)
23. Guerin M, Sheng ZM, Andrieu N, Riou G. Strong association between c-myb and oestrogen-receptor expression in human breast cancer. Oncogene 1990;5:131-5. (Pubitemid 20044814)
24. Miller BE, Roi LD, Howard LM, Miller FR. Quantitative selectivity of contact-mediated intercellular communication in a metastatic mouse mammary tumor line. Cancer Res 1983;43:4102-7. (Pubitemid 13041037)
25. Lelekakis M, Moseley JM, Martin TJ, Hards D, Williams E, Ho P, et al. A novel orthotopic model of breast cancer metastasis to bone. Clin Exp Metastasis 1999;17:163-70. (Pubitemid 29335443)
26. David G, Van der Schueren B, Bernfield M. Basal lamina formation by normal and transformed mouse mammary epithelial cells duplicated in vitro. J Natl Cancer Inst 1981;67:719-28. (Pubitemid 11050945)
27. Malaterre J, Carpinelli M, Ernst M, Alexander W, Cooke M, Sutton S, et al. c-Myb is required for progenitor cell homeostasis in colonic crypts. Proc Natl Acad Sci U S A 2007;104:3829-34. (Pubitemid 47181539)
28. Richert MM, Schwertfeger KL, Ryder JW, Anderson SM. An atlas of mouse mammary gland development. J Mammary Gland Biol Neoplasia 2000;5:227-41. (Pubitemid 32045698)
29. Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, et al. A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 1991;65:677-89.
30. Toscani A, Mettus RV, Coupland R, Simpkins H, Litvin J, Orth J, et al. Arrest of spermatogenesis and defective breast development in mice lacking A-myb. Nature 1997;386:713-7. (Pubitemid 27193491)
31. Yuan T, Wang Y, Pao L, Anderson SM, Gu H. Lactation defect in a widely used MMTV-Cre transgenic line of mice. PLoS One 2011;6:e19233.
32. Jeselsohn R, Brown NE, Arendt L, Klebba I, Hu MG, Kuperwasser C, et al. Cyclin D1 kinase activity is required for the self-renewal of mammary stem and progenitor cells that are targets of MMTV-ErbB2 tumorigenesis. Cancer Cell 2010;17:65-76.
33. Watkin H, Richert MM, Lewis A, Terrell K, McManaman JP, Anderson SM. Lactation failure in Src knockout mice is due to impaired secretory activation. BMC Dev Biol 2008;8:6.
34. Ramsay RG, Malaterre J. Insights into c-Myb functions through investigating colonic crypts. Blood Cells Mol Dis 2007;39:287-91. (Pubitemid 47484465)
35. Nicolau M, Levine AJ, Carlsson G. Topology based data analysis identifies a subgroup of breast cancers with a unique mutational profile and excellent survival. Proc Natl Acad Sci U S A 2011;108:7265-70.
36. Thorner AR, Parker JS, Hoadley KA, Perou CM. Potential tumor suppressor role for the c-Myb oncogene in luminal breast cancer. PLoS One 2010;5:e13073.
37. Zhang GJ, Kimijima I, Tsuchiya A, Abe R. The role of bcl-2 expression in breast carcinomas (Review). Oncol Rep 1998;5:1211-6. (Pubitemid 28372589)
38. Lauder A, Castellanos A, Weston K. c-Myb transcription is activated by protein kinase B (PKB) following interleukin 2 stimulation of Tcells and is required for PKB-mediated protection from apoptosis. Mol Cell Biol 2001;21:5797-805. (Pubitemid 32737797)
39. Ciznadija D, Tothill R, Waterman ML, Zhao L, Huynh D, Yu RM, et al. Intestinal adenoma formation and MYC activation are regulated by cooperation between MYB and Wnt signaling. Cell Death Differ 2009;16:1530-8.
40. Nicolaides NC, Gualdi R, Casadevall C, Manzella L, Calabretta B. Positive autoregulation of c-myb expression via Myb binding sites in the 50 flanking region of the human c-myb gene. Mol Cell Biol 1991;11:6166-76. (Pubitemid 21895389)
41. Bender TP, Thompson CB, KuehlWM.Differential expression of c-myb mRNA in murine B lymphomas by a block to transcription elongation. Science 1987;237:1473-6. (Pubitemid 17136212)
42. Hugo H, Cures A, Suraweera N, Drabsch Y, Purcell D, Mantamadiotis T, et al. Mutations in the MYB intron I regulatory sequence increase transcription in colon cancers. Genes Chromosomes Cancer 2006;45:1143-54. (Pubitemid 44763442)
43. Toth CR, Hostutler RF, Baldwin AS Jr, Bender TP. Members of the nuclear factor kappa B family transactivate the murine c-myb gene. J Biol Chem 1995;270:7661-71.
44. Watson RJ. A transcriptional arrest mechanism involved in controlling constitutive levels of mouse c-myb mRNA. Oncogene 1988;2:267-72. (Pubitemid 18085306)
45. Lin EY, Jones JG, Li P, Zhu L, Whitney KD, Muller WJ, et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am J Pathol 2003;163:2113-26. (Pubitemid 37310040)
46. Yang X, Edgerton SM, Kosanke SD, Mason TL, Alvarez KM, Liu N, et al. Hormonal and dietary modulation of mammary carcinogenesis in mouse mammary tumor virus-c-erbB-2 transgenic mice. Cancer Res 2003;63:2425-33. (Pubitemid 36605179)
47. Mizuguchi G, Kanei-Ishii C, Takahashi T, Yasukawa T, Nagase T, Horikoshi M, et al. c-Myb repression of c-erbB-2 transcription by direct binding to the c- erbB-2 promoter. J Biol Chem 1995;270: 9384-9.
48. Hamilton AS, Mack TM. Puberty and genetic susceptibility to breast cancer in a case-control study in twins. N Engl J Med 2003;348:2313- 22.
49. Williams BB, Wall M, Miao RY, Williams B, Bertoncello I, Kershaw MH, et al. Induction of T cell-mediated immunity using a c-Myb DNA vaccine in a mouse model of colon cancer. Cancer Immunol Immunother 2008;57:1635-45.